The UK is preparing for a much more complicated era of artificial intelligence in healthcare.
The National Commission into the Regulation of AI in Healthcare has published 44 recommendations for a future regulatory framework covering AI used across the health system. The proposals include continuous monitoring, cybersecurity requirements, workforce training, patient transparency and clearer rules around responsibility when AI contributes to harm.
The recommendations arrive as AI tools move deeper into clinical environments. They are already being used for disease detection, clinical decision support and medical documentation, while consumer-facing health apps and AI chatbots are creating another layer of regulatory complexity.
The Commission’s message is fairly clear: regulating healthcare AI like a conventional medical device may no longer be enough.
Healthcare AI Needs Regulation That Can Change With the Technology
Traditional medical devices are usually assessed around products that remain relatively stable after reaching the market. Artificial intelligence does not always work that way. Models can receive updates, behave differently across patient populations and produce different results depending on the clinical environment where they are deployed. Some systems may also become more capable over time.
The Commission therefore wants the UK’s regulatory approach to follow AI products throughout their lifecycle rather than treating approval as the end of the process. Its framework focuses on proportionate lifecycle regulation, clearer responsibility across the healthcare system and greater trust and transparency. That would mean evaluating an AI system before deployment, monitoring how it behaves in real healthcare settings and responding when its performance or risks change.
UK Could Introduce More Flexible Routes for AI Medical Devices
One recommendation calls for clearer rules determining when software or an AI product should legally qualify as a medical device. The Commission wants regulators to consider clinical risk, possible patient benefits, the product lifecycle and international regulatory alignment when making that decision.
It also wants the Medicines and Healthcare products Regulatory Agency to review existing UK medical device regulations and clarify areas where certain AI products may sit outside current rules. Another proposal would allow staged market access for some technologies, giving developers a controlled route into healthcare environments while they continue gathering evidence on safety and effectiveness.
This approach could make it easier for promising AI systems to reach clinical settings without assuming that every uncertainty has already been resolved before deployment.
Real-World Evidence Could Become Much More Important
Testing an AI model in a controlled environment can show whether it performs well under specific conditions, but healthcare rarely stays that predictable. Performance can shift across hospitals, clinicians, datasets and patient groups.
The Commission wants greater use of real-world evidence after deployment so regulators and healthcare organisations can monitor whether AI systems continue to perform safely and effectively. Regulatory sandboxes could also provide controlled environments where developers and authorities test emerging technologies before wider adoption.
This matters because strong performance in one hospital does not automatically guarantee the same results somewhere else. Real-world monitoring could become one of the most important safeguards as healthcare AI becomes more widespread.
Health Equity Becomes Part of AI Safety
Bias is not treated as a side issue in the Commission’s recommendations. Health equity is positioned as part of evaluating whether AI systems are safe and effective.
Regulators may need to examine whether healthcare AI performs consistently across different patient groups rather than relying only on overall accuracy figures. A system can appear highly effective on paper while still producing weaker results for certain populations.
For AI developers, this could make representative testing and diverse datasets much more important. It also puts pressure on healthcare organisations to understand who benefits from an AI system and who might face greater risk if the technology performs unevenly.
Agentic AI Is Already on the Regulatory Radar
The Commission is also looking beyond the AI tools currently common in hospitals. Its recommendations specifically mention agentic AI, which refers to systems capable of pursuing goals and completing tasks with a degree of autonomy.
That could become significant as healthcare AI moves beyond systems that simply generate predictions or summaries. Future platforms may coordinate administrative processes, interact with other software, manage workflows or carry out multiple actions with limited human intervention.
The regulatory question then becomes more difficult. It is no longer only about whether an AI prediction is accurate. Regulators may also need to decide what an AI system should be allowed to do, how much autonomy it should have and when human supervision must remain mandatory.
Doctors and Healthcare Staff Could Need Formal AI Training
Putting AI systems inside hospitals without preparing the people expected to use them could create additional risks. The Commission recommends including AI in professional education, postgraduate training and continuing professional development.
Healthcare providers may also need to give staff training tailored to the specific systems being introduced into their organisations. Clinicians would not be expected to become machine-learning engineers, but they would need to understand what a system does, where its limitations sit and when relying on an AI-generated output could become unsafe.
The wider goal is to keep AI in a supporting role. The Commission argues that artificial intelligence should augment healthcare professionals rather than replace them, leaving clinicians focused on judgment, communication, compassion and shared decision-making.
Who Is Responsible When Healthcare AI Goes Wrong?
Responsibility remains one of the hardest issues surrounding healthcare AI. The Commission argues that accountability cannot sit with one organisation or one professional alone.
Manufacturers, healthcare providers, clinicians, regulators and policymakers all have roles in maintaining safe deployment. The recommendations call for clearer agreements around cybersecurity, staff training, monitoring and safeguards, while also pushing for greater clarity around liability when an AI-enabled system contributes to patient harm.
Patients should not lose their ability to challenge harmful outcomes simply because artificial intelligence was involved somewhere in the decision-making process. The Commission acknowledges that wider legal reforms may eventually be needed, but healthcare organisations still need practical accountability mechanisms in place now.
Patients Could Get More Information About AI in Their Care
Transparency is another major part of the proposed framework. Patients should be able to understand when AI has influenced their care and should have access to practical ways of seeking clarification or redress when something goes wrong.
The Commission also wants patients and the wider public to remain involved as healthcare AI regulation develops. Public attitudes toward artificial intelligence can shift quickly, especially after high-profile successes, failures or the introduction of more autonomous systems.
Regularly measuring public and professional confidence could help regulators identify where trust is increasing and where concerns remain unresolved.
Cybersecurity Rules Could Become Tougher
AI introduces another potential attack surface inside healthcare systems that already handle highly sensitive medical information. The Commission recommends stronger cybersecurity requirements alongside clearer responsibilities between manufacturers and healthcare providers.
Consumer health applications and wearable technologies may also need clearer guidance. That expands the regulatory discussion beyond AI systems operating inside hospitals and clinics.
People increasingly encounter health-related algorithms through smartwatches, wellness platforms, mobile apps and general-purpose AI assistants. As those tools become more influential, regulators may need to think more carefully about where medical advice ends and consumer technology begins.
The UK Wants AI Regulation Without Slowing AI Innovation
There is a balancing act running through the entire proposal. The UK wants stronger patient protections, but it also wants a regulatory environment that remains attractive to AI developers, healthcare companies and investors.
That explains recommendations around regulatory sandboxes, staged routes to market and possible recognition pathways involving selected international regulators. These mechanisms could reduce unnecessary friction while still maintaining safeguards around patient safety.
The challenge is keeping those two goals aligned. Regulation that moves too slowly could allow unsafe systems to spread, while regulation that becomes too rigid could make it harder for useful technologies to reach patients.
What Happens Next?
The Commission’s 44 recommendations do not automatically become law. The National Commission is an independent advisory body, meaning its proposals provide a framework for policymakers rather than creating immediate legal obligations.
A wider government response is expected to determine which recommendations may move forward and how they could be implemented across the healthcare system. That next stage will show how much of the Commission’s blueprint turns into actual regulation.
Artificial intelligence is already part of modern healthcare. The debate is shifting away from whether AI should be used and toward harder questions about oversight, accountability, safety, transparency and autonomy. The UK Commission has now placed those questions firmly on the regulatory agenda.
Sources
MobiHealthNews:
https://www.mobihealthnews.com/news/uk-commission-proposes-new-healthcare-ai-regulations
UK Government – National Commission into the Regulation of AI in Healthcare:
https://www.gov.uk/government/publications/national-commission-into-the-regulation-of-ai-in-healthcare-recommendations-for-a-future-regulatory-framework/national-commission-into-the-regulation-of-ai-in-healthcare-recommendations-for-a-future-regulatory-framework
